___

Abbott, F. M. (2005). The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health. The American Journal of International Law, Vol. 99, No. 2, April 2005, 317-358.

Anderson, H. E. (2010). We Can Work It Out: Co-op Compulsory Licensing as the Way Forward in Improving Access to Anti-Retroviral Drugs. 16 B. U. J. Sci. & Tech. L. 167, 2010.

Bird, R. C. (2008). Can Compulsory Licensing Improve Access to Essential Medicines? http://ssrn.com/abstract=1124035 Date of Access: 30.11.2016

Cook, T. (2009). Pharmaceuticals Biotechnology and the Law, 2nd ed. United Kingdom: LexisNexis.

Correa, C. M. (2007). Trade Related Aspects of Intellectual Property Rights, A Commentary on the TRIPS Agreement. New York: Oxford University Press.

Cullet, P. (2003). Patents and Medicines: The Relationship between TRIPS and the Human Right to Health. International Affairs (Royal Institute of International Affairs 1944-), Vol. 79, No.1, January 2003, 139-160.

Domeij, B. (2000). Pharmaceutical Patents in Europe. Stockholm: Norstedts Juridik.

Gathii, J. T. (2002). The Doha Declaration on Trips and Public Health Under the Vienna Convention of the Law of Treaties. Harvard Journal of Law and Technology, Vol. 15, No. 2, 2002.

Gervais, D. (2008). The TRIPS Agreement: Drafting History and Analysis, 3rd ed. London: Sweet & Maxwell.

Grubb, P. W. (2004). Patents for Chemicals Pharmaceuticals and Biotechnology, Fundamentals of Global Law, Practice and Strategy, 4th ed. Great Britain: Oxford University Press.

Gumbel, M. (2008). Is Article 31bis Enough? The Need to Promote Economies of Scale in the International Compulsory Licensing System. Temple International & Comparative Law Journal, Volume 22, Number 1, Spring 2008.

Lidgard, H. H. & Atik J. (2005). Facilitating Compulsory Licensing under TRIPS in Response to the AIDS Crisis in Developing Countries. Loyola LA-Legal Studies Paper No. 2005-18, August 2005.

Love, R. (2007). Corporate Wealth or Public Health? WTO/TRIPS Flexibilities and Access to HIV/AIDS Antiretroviral Drugs by Developing Countries. Development in Practice, Vol. 17, No. 2, April 2007, 208-219.

Matthews, D. (2005). TRIPS flexibilities and Access to medicines in developing countries: the problem with technical assistance and free trade agreements. E.I.P.R. 2005, 27(11), 420-427.

Matthews, D. (2010). Intellectual Property Rights, Human Rights and the Right to Health. In W. Grosheide, Intellectual Property and Human Rights: A Paradox (pp. 118-139). Cheltenham: Edward Elgar Publishing Limited.

Outterson, K. (2005). Fair Followers: Expanding Access to Generic Pharmaceuticals for Low-and Middle-Income Populations. THE POWER OF PILLS, J. C. Cohen, P. Illingworth, U. Schuklenk, eds., University of Michigan Press, 2005.

Paas, K. (2009). Compulsory licensing under the TRIPS Agreement - a cruel taunt for developing countries? E.I.P.R. 2009, 31(12), 609-613.

Tekinalp, Ü. (2012). Fikri Mülkiyet Hukuku, 5th ed, İstanbul: Vedat Kitapçılık.

Van Overwalle, G. & Van Zimmeren, E. (2011) "A Paper Tiger? Compulsory License Regimes for Public Health in Europe", International Review of Intellectual Property and Competition Law (IIC), January 2011.

Vaver, D. & Basheer, S. (2006). Popping patented pills: Europe and a decade's dose of TRIPS. E.I.P.R. 2006, 28(5), 282-291.

Wakely, J. (2011). Compulsory licensing under TRIPs: an effective tool to increase access to medicines in developing and least developed countries? E.I.P.R. 2011, 33(5), 299-309.

Legislation

Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), Marrakesh, 15 April 1994.

Convention on the Grant of European Patents (European Patent Convention), Munich, 5 October 1973 as revised by the Act revising Article 63 EPC of 17 December 1991 and the Act revising the EPC of 29 November 2000.

Decision No 1/95 of the EC-Turkey Association Council of 22 December 1995 on implementing the final phase of the Customs Union, OJ 1996 L35/1-47.

Decree-Law No. 551 of 06.24.1995 on the Protection of Patent Rights, OG No: 22326, 27.06.1995.

Directive 2004/27/EC of 31 March 2004 amending Directive 2001/83/EC on the Community Code relating to medicinal products for human use, OJ L 136, 28.11.2004 1.)

European Social Charter (Revised), Strasbourg, 3.5.1996.

International Covenant on Economic, Social and Cultural Rights, GA Res. 2200A (XXI), 16 December 1966 entry into force 3 January 1976.

Law No. 4054 of 07.12.1994 on the Protection of Competition, OG No: 22140, 13.12.1994.

Law No. 5042 of 08.01.2004 on the Protection of Plant Breeders’ Rights for New Plant Varieties, OG No: 25347, 15.01.2004.

Law No. 6471 of 30.04.2014, OG No: 28654, 23.05.2013.

Law No. 6769 of 22.12.2016 on Industrial Property, OG No: 29944, 10.01.2017.

Previous text of the Draft Law amending Decree-Law No. 551 on the Protection of Patent Rights. http://www2.tbmm.gov.tr/d24/1/1-0756.pdf Date of Access: 07.01.2017.

Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems, OJ 2006 L/157/1.

United Nations (UN) General Assembly, Universal Declaration of Human Rights, Paris, 1948.

Documents (WTO & EU)

Annex to the Decision 2003, Assessment of Manufacturing Capacities in the Pharmaceutical Sector. Declaration on the TRIPS Agreement and Public Health, Doha, 14 November 2001.

World Trade Organization, Amendment of the TRIPS Agreement, Decision of the General Council of 6 December 2005.

World Trade Organization, Implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health, Decision of the General Council of 30 August 2003.

World Health Organization and Health Action International, Measuring medicine prices, availability, affordability and price components, 2nd ed, 2008, WHO/PSM/PAR/2008.3 http://apps.who.int/ medicinedocs/index/assoc/s14868e/s14868e.pdf Date of Access: 30.11.2016

World Trade Organization, Intellectual Property: Members accepting amendment of the TRIPS Agreement. https://www.wto.org/english/tratop_e/ trips_e/amendment_e.htm Date of Access: 30.11.2016

World Trade Organization, Press/426, Intellectual Property: Members OK amendment to make health flexibility permanent, 6 December 2005.

WT/L/711, World Trade Organization, Amendment of the TRIPS Agreement – Extension of the Period for the Acceptance by Members of the Protocol Amending the TRIPS Agreement, Decision of 18 December 2007.

WT/L/785, World Trade Organization, Amendment of the TRIPS Agreement – Second Extension of the Period for the Acceptance by Members of the Protocol Amending the TRIPS Agreement, Decision of 17 December 2009.

WT/L/829, World Trade Organization, Amendment of the TRIPS Agreement – Third Extension of the Period for the Acceptance by Members of the Protocol Amending the TRIPS Agreement, Decision of 30 November 2011.

WT/L/965, World Trade Organization, Amendment of the TRIPS Agreement – Fifth Extension of the Period for the Acceptance by Members of the Protocol Amending the TRIPS Agreement, Decision of 30 November 2015.

SPEECH/05/747, Peter Mandelson, Remarks to the European Parliament Plenary Mini-Session – Doha and Development, Brussels, 30 November 2005.